Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: A high serum creatine kinase (CK)-MB-to-total-CK ratio in patients with pancreatic cancer: a novel application of a traditional marker in predicting malignancy of pancreatic masses?

Fig. 2

Comparisons of CK ratios among the different groups. A A subgroup analysis of the PC group was performed after stratification according to tumor stage (I/II and III/IV) to compare the data with the control and BPM groups (different color saturations represent the different health conditions of the subjects in the groups). The CK ratio in the III/IV group, but not the I/II group, was significantly higher than that in the BPM group. B The whole BPM group showed a significantly lower CK ratio than the PC group. *P<0.05, **P<0.01, and ***P<0.001. BPM, pancreatic benign mass; PC, pancreatic cancer; SCN, serous cystic neoplasm; MCN, mucinous cystic neoplasm; IPMN, intraductal papillary mucinous neoplasm; SPN, solid pseudopapillary neoplasm; MFCP, mass-forming chronic pancreatitis

Back to article page